ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

QURE uniQure NV

4.81
0.13 (2.78%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
uniQure NV QURE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.13 2.78% 4.81 07:41:32
始値 安値 高値 終値 前日終値
4.78 4.66 4.965 4.69 4.68
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/0607:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2906:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2822:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2822:00EDGAR2Form 8-K - Current report
2024/2/2821:05GLOBEuniQure Announces 2023 Financial Results and Highlights..
2024/2/2706:46EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2706:25EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1406:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/1921:12EDGAR2Form 8-K - Current report
2023/12/1921:05GLOBEuniQure Announces Update on Phase I/II Clinical Trials of..
2023/12/1209:30PRNUSCSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb)..
2023/12/0821:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
2023/11/2921:05GLOBEuniQure Announces FDA Clearance of Investigational New Drug..
2023/11/1720:00EDGAR2Form 8-K - Current report
2023/11/0721:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0721:31EDGAR2Form 8-K - Current report
2023/11/0721:05GLOBEuniQure Announces Third Quarter 2023 Financial Results and..
2023/10/2723:00PRNUSCSL and uniQure Win 2023 Prix Galien USA Award
2023/10/2703:38PRNCASanté Canada autorise HEMGENIX® de CSL (étranacogène..
2023/10/2703:14PRNCAHealth Canada Authorizes CSL's HEMGENIX® (etranacogene..
2023/10/2420:05GLOBEuniQure Announces Major Presence at the European Society of..
2023/10/0619:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/10/0619:32EDGAR2Form DEF 14A - Other definitive proxy statements
2023/10/0605:32EDGAR2Form 8-K - Current report
2023/10/0520:05GLOBEuniQure Announces Strategic Reorganization to Reduce..
2023/10/0310:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0220:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
2023/9/2105:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0602:59DJNRe/Max, UniQure and Trinseo Fall to 52-Week Lows on Exit..
2023/9/0520:05GLOBEuniQure Announces FDA Clearance of Investigational New Drug..
2023/9/0207:51PRNUSBlackstone and Airbnb Set to Join S&P 500; Others to Join..
2023/8/0205:30EDGAR2Form 8-K - Current report
2023/8/0120:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0120:05GLOBEuniQure Announces Second Quarter 2023 Financial Results and..
2023/7/1305:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1023:58EDGAR2Form 144 - Report of proposed sale of securities
2023/6/2620:11GLOBEuniQure Announces Leadership Addition to Support Advancement..
2023/6/2120:05GLOBEuniQure Announces Update on U.S. Phase I/II Clinical Trial..
2023/6/2020:05GLOBEuniQure announces achievement of $100 million..
2023/6/2020:00PRNUSCSL Behring Announces the First Patient Has Received..
2023/6/1620:05GLOBEuniQure Announces Inducement Grants Under Nasdaq Listing..
2023/5/1520:05GLOBEuniQure Announces Sale of Royalty Interest in HEMGENIX® for..
2023/5/0920:05GLOBEuniQure Announces First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock